Authors

• Nathalie Vaissière
• Nadine C. Salisch (ORCID: https://orcid.org/0000-0002-2951-0800)
• Sophie Cambre
• Gloria Aguilar (ORCID: https://orcid.org/0000-0001-8341-701X)
• Gert C. Scheper (ORCID: https://orcid.org/0000-0003-2316-756X)
• Erik Buntinx
• Macaya Douoguih (ORCID: https://orcid.org/0000-0002-2707-5729)
• Sunila Pradeep
• Frank Struyf (ORCID: https://orcid.org/0000-0001-9988-0260)
• Robert M. Patrizi
• Gerald Weidinger
• Pedro Ylisastigui (ORCID: https://orcid.org/0000-0002-4850-6890)
• Maria Grazia Pau (ORCID: https://orcid.org/0000-0002-8995-9693)
• Gabriela Tapia-Calle (ORCID: https://orcid.org/0000-0001-9509-7412)
• Javier Ruiz‐Guiñazú (ORCID: https://orcid.org/0000-0001-6941-3100)
• Carla Truyers
• Wenhua Ling (ORCID: https://orcid.org/0000-0002-5468-6605)
• M. de Groot
• Sanne de Ridder
• Mathieu Le Gars

Institutions

• Janssen (Belgium) (BE)
• Alliance for Multispecialty Research (United States) (US)
• Janssen (Netherlands) (NL)

Publication Details

Journal

EClinicalMedicine

Published

2025-01-01

DOI

https://doi.org/10.1016/j.eclinm.2024.103016

Citations

3

Primary Topic

SARS-CoV-2 and COVID-19 Research

Type

article

Field-Weighted Citation Impact

4.19

Funders

• U.S. Department of Defense
• U.S. Department of Health and Human Services
• National Institutes of Health
• Biomedical Advanced Research and Development Authority